Skip to content
Friday, 20 November 2026
BREAKING
HEALTH

Major Crackdown on Fake Drug Network in Uttar Pradesh: ₹7.57 Crore Worth of Medicines Seized

Uttar Pradesh authorities seize fake drugs worth ₹7.57 crore and file 24 FIRs against a widespread counterfeit medicine network.

Lucknow, November 20 (Daily Kiran) : A significant operation against the illegal trade of counterfeit and fake medicines is underway in Uttar Pradesh, revealing a complex network involved in the distribution of these products. Authorities have seized fake drugs worth ₹7.57 crore and filed 24 FIRs, targeting a network that has expanded its operations not only within the state but also to neighboring regions.

The Uttar Pradesh Food Safety and Drug Administration (UPFSDA) has uncovered that this illegal operation utilized fake billing practices, multiple drug licenses, and various firms operating under the same name. The investigation has implicated 45 firms and 90 individuals.

A case from Amroha and Moradabad illustrates how the network functioned. Here, eight drug firms were licensed under a single name and partnership, facilitating the storage and illegal trade of medicines through fraudulent billing instead of legitimate retail sales. Police have arrested three suspects in connection with this case.

The UPFSDA is also probing the primary sources of counterfeit drug manufacturing and related supply chains. A sample of Moxifit-CV 625 tablets was collected from RB Medical Store in Chowdhurpur, Amroha, on June 12, 2026. Tests confirmed the sample was fake, leading to verification with the actual manufacturer, Polister Power Industries, and marketer Healthpride, both of whom confirmed the batch was counterfeit.

Further investigations traced the network back to Moradabad’s ZR Medical, revealing that the accused had obtained licenses for eight different firms under the same name and partnership. These firms were involved in the storage and illegal distribution of fake drugs rather than legitimate sales.

During a surprise inspection directed by headquarters, it was discovered that Amit Kumar, a partner at Eriba Pharmaceuticals, had received and distributed counterfeit drugs from Asif. Following this, an FIR was registered against Amit Kumar, Asif, Wasif, and others at the Civil Lines police station in Moradabad.

The police have since arrested Ravinder, Shivam, and Asif while the investigation continues to identify the main manufacturing sources of the fake drugs. Additionally, actions are being taken to revoke the drug licenses of firms involved in this illegal trade.

The investigation has revealed that counterfeit drugs are being produced under the branding and labeling of well-known pharmaceutical companies. Confirmed counterfeit brands include Glenmark’s Telma, Abbott’s Kenacort Injection, and others from prominent companies like Eristo Pharma, Alkem, Glaxo, and Mankind.

The scope of this counterfeit drug operation extends beyond a single product or brand. It includes fake versions of antibiotics, pain relievers, gastric medications, and other therapeutic drugs. So far, 24 FIRs have been filed in connection with the illegal manufacturing, storage, and sale of counterfeit medicines.

In total, FIRs have been registered across various districts, including nine each in Agra and Lucknow, and two in Varanasi. Investigations have also uncovered illegal manufacturing units in other states, including two in Dehradun, one in Ujjain, and two in Solan, Himachal Pradesh. The department is now examining suppliers and firms linked to these operations.

Several individuals have been identified in multiple FIRs, including Bhupendra Sharma, Vineet Kumar, and others. Investigative agencies are scrutinizing these individuals’ connections to drug manufacturing, fake billing, storage, and distribution networks. The next crucial step in the UPFSDA’s investigation is to trace the actual sources of counterfeit drug production, including their packaging and distribution channels.

Share